Pharmacological treatment of postmenopausal osteoporosis

Daniel G. Fernández Ávila; Claudia Mora; Elsa Reyes Sanmiguel; John Darío Londoño; Pedro Santos Moreno; Rafael Valle-Oñate

doi:10.1016/S0121-8123(10)70084-0

Pharmacological treatment of postmenopausal osteoporosis

Daniel G. Fernández Ávila
, Claudia Mora
, Elsa Reyes Sanmiguel
, John Darío Londoño
, Pedro Santos Moreno
, Rafael Valle-Oñate

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

Osteoporosis is a silent illness until fractures appears, with a very high economic and social cost for the patient and the health system, representing a true problem of public health. Postmenopausal women have a higher risk of osteoporosis and fracture. Actually are available different drugs that through a varied mechanism of action, increase bone mineral density and reduce fracture risk. In this article we present relevant information about the pharmacology and clinical effectiveness of each one of drugs used in the treatment of osteoporosis.

Translated title of the contribution	Tratamiento farmacológico de la osteoporosis postmenopáusica
Original language	English
Pages (from-to)	96-110
Number of pages	15
Journal	Revista Colombiana de Reumatologia
Volume	17
Issue number	2
DOIs	https://doi.org/10.1016/S0121-8123(10)70084-0
State	Published - 01 Jun 2010
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

bone mineral density
fracture
menopause
osteoporosis

Access to Document

10.1016/S0121-8123(10)70084-0

Cite this

@article{5b1e0ac9fd56497eaa8dd84a9d121891,

title = "Pharmacological treatment of postmenopausal osteoporosis",

abstract = "Osteoporosis is a silent illness until fractures appears, with a very high economic and social cost for the patient and the health system, representing a true problem of public health. Postmenopausal women have a higher risk of osteoporosis and fracture. Actually are available different drugs that through a varied mechanism of action, increase bone mineral density and reduce fracture risk. In this article we present relevant information about the pharmacology and clinical effectiveness of each one of drugs used in the treatment of osteoporosis.",

keywords = "bone mineral density, fracture, menopause, osteoporosis",

author = "\{Fern{\'a}ndez {\'A}vila\}, \{Daniel G.\} and Claudia Mora and Sanmiguel, \{Elsa Reyes\} and Londo{\~n}o, \{John Dar{\'i}o\} and Moreno, \{Pedro Santos\} and Rafael Valle-O{\~n}ate",

note = "Publisher Copyright: {\textcopyright} 2010 Asociaci{\'o}n Colombiana de Reumatolog{\'i}a",

year = "2010",

month = jun,

day = "1",

doi = "10.1016/S0121-8123(10)70084-0",

language = "English",

volume = "17",

pages = "96--110",

journal = "Revista Colombiana de Reumatologia",

issn = "0121-8123",

publisher = "Asociacion Colombiana de Reumatologia",

number = "2",

}

TY - JOUR

T1 - Pharmacological treatment of postmenopausal osteoporosis

AU - Fernández Ávila, Daniel G.

AU - Mora, Claudia

AU - Sanmiguel, Elsa Reyes

AU - Londoño, John Darío

AU - Moreno, Pedro Santos

AU - Valle-Oñate, Rafael

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Osteoporosis is a silent illness until fractures appears, with a very high economic and social cost for the patient and the health system, representing a true problem of public health. Postmenopausal women have a higher risk of osteoporosis and fracture. Actually are available different drugs that through a varied mechanism of action, increase bone mineral density and reduce fracture risk. In this article we present relevant information about the pharmacology and clinical effectiveness of each one of drugs used in the treatment of osteoporosis.

AB - Osteoporosis is a silent illness until fractures appears, with a very high economic and social cost for the patient and the health system, representing a true problem of public health. Postmenopausal women have a higher risk of osteoporosis and fracture. Actually are available different drugs that through a varied mechanism of action, increase bone mineral density and reduce fracture risk. In this article we present relevant information about the pharmacology and clinical effectiveness of each one of drugs used in the treatment of osteoporosis.

KW - bone mineral density

KW - fracture

KW - menopause

KW - osteoporosis

UR - https://www.scopus.com/pages/publications/85025696137

U2 - 10.1016/S0121-8123(10)70084-0

DO - 10.1016/S0121-8123(10)70084-0

M3 - Review article

AN - SCOPUS:85025696137

SN - 0121-8123

VL - 17

SP - 96

EP - 110

JO - Revista Colombiana de Reumatologia

JF - Revista Colombiana de Reumatologia

IS - 2

ER -

Pharmacological treatment of postmenopausal osteoporosis

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this